Nutra Femin For
Woman
Eases Menopause Symptoms
The Menopause Reporter
Become a STAR Become a STAR Washington, DC October 12, 1999 --
call the National Cancer Institute's Cancer Information Service at: 1-800-4-CANCER (1-800-422-6237) New York, N.Y. October 5, 1999 -- If your menses are occurring sooner than 21 days it may be perimenopause or a more serious gynecological condition and you need to be evaluated by your health care provider. Menses occurring later than 45 days is more consistent with menopause or perimenopause. If physical symptoms predominate, especially hot flashes, vaginal dryness and night sweats, and if they last throughout the month unrelated to menses think more about menopause. Remember menopause before the age of 40 is called premature menopause and is rare. However perimenopause can begin before age 40. Surgical removal of the ovaries is the most common cause of premature menopause. Hopefully you know if your ovaries have been removed, but you may not. Years ago doctors routinely removed ovaries in women undergoing a hysterectomy (removal of the uterus). Now many gynecologists do not remove the ovaries. Until you are firmly in menopause, that is, no periods for one year, you can still get pregnant. If you don't smoke, low dose oral contraceptives can be used right up to menopause. Hopefully your calendar will help you become more familiar with your symptoms. From here you can design a PMS / perimenopause / menopause treatment plan. Perimenopause, a Hot Topic for U.S. Doctors (Part Two)New York, N.Y. September 28, 1999 -- You start with your past. The age your mother or older sisters began menopause can have a bearing on when you will begin menopause. If your mother went through menopause in her late 40's and you're 34 it is most likely PMS. If your mother suffered from PMS then you are more likely to suffer as well. However, your mother might not remember when she went through menopause and your older sister may not admit to it. The only other reliable factor is if you smoke. If you smoke, you can count on menopause starting 1-2 years earlier than if you don't. Pregnancies, birth control pills, your age when you first began menses or breast-feeding have no impact on the age of menopause. If you are on oral contraceptives or other hormones such as Depo-Provera or estrogen, these can have an effect on mood, irritability, hot flashes, depression and your periods. Women who can't tolerate birth control pills are more likely to develop PMS and have a difficult perimenopause. Adjusting the dose, brand or time you take these medications can sometimes relieve unwanted side effects. Some of the symptoms of depression are found in both PMS and perimenopause. Depression is not caused by menopause, but it can run in families. If feelings of depression, loss of appetite, insomnia, and general loss of interest or pleasure in life are at the top of your list you may be suffering from clinical depression. These feelings should be brought to the attention of your health care provider. Depression and PMS can occur together and it's not uncommon for anxiety or depressive disorders to worsen during the week before your period and at menopause. Sound confusing? Well, it can be. All of the above statements are generalizations but you have to remember that you are a unique individual. Watch for part three here next week.Perimenopause, a Hot Topic for U.S. Doctors New York, N.Y. September 21, 1999 -- Perimenopause is defined as the TRANSITIONAL period from normal menstrual periods to no periods at all. The transition can, and usually does, take up to ten years. During the perimenopausal transition you may experience a combination of PMS and menopausal symptoms or no symptoms at all. Check back next week for the latest from New York on the perimenopause. Protect Yourself from Gynecological Cancer Chicago, IL. September 14,1999 -- September is gynecological cancer awareness
month. Every 64 minutes a women is diagnosed with gynecological cancer. The most
common female reproductive system cancers are cervical, ovarian and uterine.
September is Menopause Awareness Month New York, NY. September 7, 1999 -- Since September is menopause awareness
month I thought a little historical perspective might be appropriate. Menopausal
women have been neglected and ridiculed by society and generally under-served by
the medical community. Women going through "The Change" have been
characterized by society as raving and frantic or muddleheaded and oblivious.
The following is a quote taken from an 1887 neurological textbook:
"The ovaries, after long years of service, have not the ability of retiring in graceful old age, but become irritated, transmit these irritations to the abdominal ganglia, which in turn transmit the irritation to the brain producing disturbances in the cerebral tissue exhibiting themselves in extreme nervousness or in an outburst of actual insanity." This unsympathetic attitude has mellowed somewhat. Today women live to an
average age of seventy-eight. They may spend as much as a third of their lives
in menopause! One hundred years ago, most women saw menopause as the end of
their life and IT WAS! Life expectancy in the 19th century was age fifty. Once a
woman reached menopause, it was expected that she would soon die. Well, some
women still feel that way. Usually by the age of fifty-one the ovaries run of
eggs (ova) and stop making estrogen. This loss of estrogen causes the typical
symptoms of menopause. Premature or early menopause can be the results of surgery although not
from a simple hysterectomy (removal of the uterus) but a surgery called an
oophorectomy (removal of the ovaries). This often accompanies a hysterectomy,
especially if the woman is over forty years old. Radiation and/or chemotherapy
for the treatment of cancer can also throw a woman into a premature menopause.
In some cases a gender disorder, which can be handed down from mother to
daughter, can cause premature ovarian failure. Menopause is a natural transition and the more people who are made aware of
this fact the better for all of us. Boston, MA. August 31, 1999 -- Brisk walking is associated with a decrease in
heart disease according to a recent study in the August 26 issue of The New
England Journal of Medicine. Walking was compared with vigorous exercise in
72,488 female nurses who were 40 to 65 years old. The nurses have been studied
for the past 8 years. Those women who walked at a brisk pace for three or more
hours a week had a significant reduction in their risk of heart attack. The
walkers risk of heart attack was reduced practically as much as those women who
engaged in regular vigorous exercise. Another encouraging finding is that
sedentary women who become active even later in life can lower their risk of
heart attack. For the prevention of osteoporosis it is still necessary to do
some resistive exercise. Weight lifting even with light weights can go a long
way towards bone health. So during your brisk hour walk use hand and ankle
weights for a more complete workout. (N Engl J Med 1999;341:650-8.) Bologna, Italy. August 24, 1999 -- We have a good mystery for those of you
who have increased your intake of soy. University researchers from Italy and
Wales have just published another soy study in the August issue of Obstetrics
and Gynecology. They revisited the 104 postmenopausal women in their original
study. The women had supplemented their diet with 60 g of soy powder a day and
reported a 45% decrease in frequency of hot flushes. This finding along with
previous studies showing soy's ability to reduce hot flushes has prompted
millions of women to add soy to their diet. It has always been assumed the
active ingredients are phytoestrogens. Phytoestrogens are natural, mild
estrogen-like compounds. They are found in soy and many other herbs used for
menopause. The doctors were looking at blood levels of phytoestrogens. Everyone
thought the level of phytoestrogens would be highest in the women with the
lowest frequency of hot flushes. Asian women who eat soy products every day have
high phytoestrogen levels and few hot flushes. They were surprised to find the
women with the highest levels of phytoestrogens did not necessarily have the
fewest hot flushes. So what is it in soy that works on those flushes? Dr.
Albertazzi the principle investigator at Bologna University is not sure. He and
others will keep looking for the answer as they feel soy may also decrease the
chance of developing breast cancer and osteoporosis. ObstetGynecol 1999;94:225-8. Bethlehem, PA. August 17, 1999 -- Doctors at the Department of Obstetrics and
Gynecology and Pathology at St. Luke's Hospital report that using a progesterone
cream may decrease the number of menopausal hot flashes you experience. They
studied 102 menopausal women who were divided into two groups. One group used
1/4 tsp. of natural progesterone cream on their skin daily. The other group used
a placebo, after one year both groups were compared. The researchers found that
83% of the group that used the progesterone cream reported less hot flashes.
Only 19% of the placebo group reported any benefit. Progestogens have been used for years in infertility treatment and to replace
the natural progesterone in women with premature ovarian failure. Progestogens
are used to treat abnormal uterine bleeding and for contraception in birth
control pills and in Depo-ProveraŇ the every 3 month
contraceptive injection. They are also used to prevent the negative effects of
estrogen on the uterus when used for hormone replacement therapy and they are
used for the treatment of PMS. There are problems with using progesterone cream for hot flashes.
"Natural progesterone cream" has been sold for years as a menopause
remedy, to cure wrinkles, osteoporosis, fatigue etc. ObstetGynecol 1999;94:225-8. Tampere, Finland. August 9, 1999 -- A new study sheds light on sleep problems
in menopause. Researchers in Finland studied 63 menopausal women in their sleep
lab. They report several things we already knew. Insomnia increases with age.
Women are more likely to suffer from insomnia than men. After hot flashes,
insomnia is the most often complained about symptom of menopause. But does
menopause and the resulting low estrogen cause sleeplessness? The scientists
conclusion was no. Menopause per se with the resulting low estrogen levels did
not cause changes in sleep patterns. What did cause insomnia was being
overweight and being old. If you suffer from insomnia every night or most nights for a period of one
month then you have chronic insomnia. If you're not having hot flashes or night
sweats then it's time to look for other causes of sleeplessness. Depression and
anxiety disorders are the most common causes of chronic insomnia. If you feel
depressed you need to be evaluated by a qualified health care provider. Movement
disorders such as restless leg syndrome are second on the list of causes of
insomnia for them; there are new medications that may help. Other common causes
are shift working, respiratory disorders and pain. In up to 30% of people with chronic insomnia no cause can be identified.
Medical treatment of these people has generally been with hypnotic drugs
(sleeping pills). It is estimated that 25% of the adult population in America
took some type of medication for sleep last year. It is generally agreed that
sleeping pills should only be in the lowest dose and for the shortest possible
time. The recommendations are;
(BEDS) Bibliographic Electronic Database of Sleep (NAPS) New Abstracts and Papers in Sleep Senate Votes Against Womens HealthWashington, DC. August 2, 1999 -- The U.S Senate still seems to be siding Senate Votes Against Womens HealthWashington, DC. August 2, 1999 -- The U.S Senate still seems to be siding
with the big HMO's when it comes to women's health. The Senate passed what they
call a "Patient's Bill of Rights". A more accurate name would be the
"Insurance Companies Bill of Wrongs". Women are still not given the
right to go directly to their ob/gyn if they find a breast lump. They must still
go through a primary care "gatekeeper". We know that a significant
delay in the diagnosis and treatment of breast cancer can result in women dying. The House is trying to organize a full scale debate. They need to here from
you. Contact your Senators and Representative at their web sites to let them
know how you feel. Your Senators
San Diego, CA. July 26, 1999 -- The Human diet contains foods that may have an influence on menopause and menopausal symptoms. Some foods have high levels of phytoestrogens, or plant estrogens. These compounds are found in soy foods, flax seeds, and some herbs. The phytoestrogenic compounds are called isoflavones and lignans. One of the first phytoestrogens to be studied was red clover. In years past it was noted that when female sheep ate a diet high in red clover, their menstrual cycles became irregular. Dr. Lisa B. Nachtigall, of Tufts University, Boston, Massachusetts, reported at The Endocrine Society meeting in San Diego last week, on a study of 16 women using a red clover based supplement for menopausal symptoms. The supplement is called Promensil by (Novagen, Inc.),and after 8 weeks patients reported a greater than 50% decrease in hot flashes and night sweats. Another clue to the fact that plant's contained estrogen-like compounds was that women in Asia, where the diet is high in soy foods, reported less menopausal symptoms and had a lower incidence of breast cancer. However when Asian women cane to America and adopted the traditional American diet their postmenopausal symptoms increased as did their incidence of breast cancer. This generated interest and further studies were undertaken. A 1990 study of 23 women showed that a diet high in soy food and flax or linseed meal reversed the atrophic changes seen in the vagina after menopause. A 1995 study of 58 post menopausal women showed that a diet high in soy
decreased postmenopausal hot flashes. There have been several studies showing a
protective effect of soybean products against the development of breast cancer.
The protective effect may be due to the fact that phytoestrogens can act both as
weak estrogens and weak anti-estrogens. It is presumed the anti-estrogen effect
on the breast confers protection against breast cancer. New York, N.Y. July 19, 1999 -- This weekend a group of scientists and
physicians gathered in New York City to discuss a new study on the problem of
vertebral fractures in postmenopausal women. The study is named PROOF and shows
how a drug called miacalcin can prevent these fractures. Your vertebra are the many small bones that form your backbone. When
osteoporosis develops these are the first bones to loose strength and this can
result in them collapsing. Vertebral fractures are a national epidemic there are
over 700,000 new fractures a year and in the past these were ignored by most
doctors. Patients were told there was nothing to be done just take pain
medication. Many vertebral fractures do not cause terrible pain they may just
cause a worsening of chronic back pain, a stooped over posture or a protuberant
abdomen. One third of women over the age of 65 suffer a vertebral fracture.
There are well established risk factors for osteoporosis. Being white or Asian
with a thin or small build are risk factors as well as being menopausal, not
getting enough calcium or taking steroids. For more information visit the National
Osteoporosis Foundation's Web site Milan, Italy July 12, 1999 -- An international panel on Hormone Replacement
Therapy (HRT) has just finished reviewing 50 years of data. They looked at the
risks and benefits of estrogen therapy for menopausal symptoms and concerns. The
panel felt that the evidence was overwhelming for the use of HRT as "first
line" therapy for menopausal symptoms such as hot flashes. The evidence
looks very good for the use of HRT for the prevention and maybe even the
treatment of osteoporosis. There is strong evidence that HRT has a protective
effect on heart disease and encouraging evidence for it's role in slowing the
onset of Alzheimer's disease and colorectal cancer. This is good news for the
millions of women now taking HRT or considering it. However there is nothing new
here. Read
the article here Miami, FL. July 5, 1999 -- Corporate America has recognized several women's
issues recently. Extended maternity leave, child care and even paternity leave
have been addressed . Menopausal issues in the work place have not been dealt
with yet. These are real concerns, hot flashes can disrupt meetings and lack of
sleep can effect performance. The workplace may be a good place for support
groups to form and educational seminars to be held. "My generation is
finally coming out and saying that it's OK to go through menopause . That's
going to make a difference, because not being able to talk about menopause is
the worse thing that a women can do." said Jane Elaine Taulé , president
of the National Association of Women Business Owners. The LifeLines Institute is a new group formed by two pharmaceutical
companies, Noven Pharmaceuticals, Inc and Novartis Pharmaceuticals Corporation.
The institute has been charged with the job of "educating corporate America
about menopause". Along with this noble pursuit they will help Novogyne
sell it's new product the Vivelle dot™. Also known as the world's smallest
estrogen replacement therapy patch, the dot has been on the market since January
and will face steep competition from the numerous other patches available. Let's
hope LifeLines keeps it's promise to bring corporate America up-to-speed on
menopause. San diego, CA June 28, 1999 -- Loss of interest in sex is a common complaint
of postmenopausal women. Testosterone is the most common androgen, and it has
been shown in several studies to improve libido ( sex drive ) when taken by
mouth. Dr. Glenn Braunstein, of Cedars-Sinai Medical Center-UCLA, Los Angeles,
California, has been studying a new testosterone patch. He has reported his
preliminary findings last week at the annual meeting of the The Endocrine
Society. The study was conducted on 75 surgically menopausal women. They used
the patch for three months, then switched to either a placebo (patch with no
medication) or a higher dose patch for three months. Overall, there was little
improvement except for those on the high dose patch who reported an increase in
sexual activity. Should you be taking an androgen product? Possibly, if any of the following
apply to you. There are other questions you must answer with your physician. What is your
risk for osteoporosis? What is your cholesterol HDL ratio? There are still
unanswered questions concerning androgens. What effect will androgens have on
heart disease and breast cancer over the long term? More long range studies are
needed. For now if you think you might be a candidate for androgen therapy, take
the information you have and discuss it with your physician Washington, D.C. June 21, 1999 -- Vice President Al Gore met recently with
the Older Women's League (OWL). The Older Women's League - let's update the
name. Even if you don't like the name you may agree with their cause. As
explained on their web site. "OWL seeks comprehensive, preventative, acute
and long-term care accessible to all, which recognizes the specifics of women's
health care profiles." In a recent conference sponsored by the OWL,
Medicare reform was discussed and a new report was made public. These are
important issue for menopausal women. Politicians know there are twice as many
women over age 85 as men, these women are more likely to be poor and have higher
health care costs than men. Fortunately they are also more likely to vote than
men. The most heated discussions centered on prescription coverage. Medicare
does not cover prescriptions, yet 80% of menopausal women are taking some
prescription medications which they have to pay for out-of-pocket. Since half of
older women have incomes less than $10,000 and drugs are notoriously expensive,
this is a hardship for many. The President of the Older Women's League Betty Lee
Ongley, summed it up by saying, "Understanding who Medicare serves and what
they need is essential as Congress begins to look at changing the
program..." Another change in the works is lowering the age of buy-in
coverage from 65 to 62. And watch out for those legislators who would like to
raise the age of eligibility from 65 to 67. It may seem a long way off, or you
may be involved with Medicare now, either way make your voice heard. Keep
informed and let your congressman and senator know your watching them. Call the OWL Congressional Information Line.
June 14 1999 -- As many of you may painfully be aware of, menopause is
associated with unwanted weight gain. Women on hormone replacement therapy don't
gain as much weight but they still may gain more than they want. Xenical, also
known by its brand name Orlistat, has just received FDA approval for weight
loss. The drug acts by blocking up to 30% of the fat you eat. Xenical works in
the intestines and is not absorbed into the blood stream. Since it is not
absorbed, there should not be any life threatening side effects. You may
remember Redux, one of the components of Fen-Phen, that caused heart valve
defects, prompting the FDA to remove it from the market. Xenical's side effects
as reported by the company "...may include oily spotting, gas with
discharge, urgent need to go to the bathroom, oily or fatty stools, increased
number of bowel movements, and inability to control bowel movements. Due to the
presence of undigested fat, the oil seen in a bowel movement may be clear or
have a coloration such as orange or brown." It may be messy but not life
threatening. For more details about
Xenical and to figure out your BMI Click Here. Boston, MA. June 7, 1999 -- Researchers at Harvard University have reported
new evidence that links early menopause and smoking to heart disease. The report
is based on the ongoing Nurses Health Study. For the past 18 years scientists
have been keeping track of over 35,000 women as they went through menopause. Dr.
Frank B. Hu has published their findings in the latest edition of the
Archives of Internal Medicine. What Dr. Hu and his associates have
discovered is that if you smoke and go through an early menopause before age 40
your risk of heart disease increases by over 53%. Menopause between age 40 and
44 increases your risk of heart disease by 42%. The problem is compounded by the
fact that smoking is known to bring on an earlier menopause. Smokers go through
menopause an average of one year earlier than nonsmokers. So now we have two
more reasons not to smoke. Not only do you risk going through an early menopause
if you smoke this study shows that your early menopause will be associated with
a higher risk of heart disease. Click
Here to read the study. Philadelphia, PA. June 1, 1999 -- Preliminary reports presented at the
American College of Obstetrics and Gynecology's annual meeting show that if
you're on the standard dose of HRT (hormone replacement therapy) you may benefit
by cutting the dose in half. Dr.Bruce Ettinger and colleagues at the Kaiser
Permanente Medical Care Program in Oakland CA. studied 138 postmenopausal women
who were on the standard dose of HRT (0.625mg) all of which had some monthly
bleeding. Bleeding is the side effect most responsible for women discontinuing
HRT. The women were switched to a half strength estrogen (0.3mg) and a progestin
used only every six months. The women have been followed now for 6 months and
they have experienced a decrease in the amount of bleeding and no worsening of
menopausal symptoms. Previous studies have shown that the half strength estrogen
confers the same protection from osteoporosis as the standard dose. This lower
dose may also provide the same protection from heart disease (studies are
underway). We may also expect to see less estrogen associated breast cancer with
this lower dose. If continued monthly bleeding is a concern, or if you're on HRT
and considering going off because of bleeding ask your doctor about lowering
your dose. Austin, TX -May 24, 1999 -- Black Cohosh or Remifemin™ is the most popular
herbal treatment for menopausal hot flashes. It has been available in Germany by
prescription since the mid 50's. The American Botanical Council and the Herb
Research Foundation have just published a 15 page literature review on black
cohosh in the journal HerbalGram. This is the most comprehensive review
available and includes a description, history, safety profile and a review of
the eight clinical studies done to date. A copy of the literature review is available from the American Botanical
Council by calling 800/373-7105 or visit their web site at HerbalGram New York, NY. - May 17, 1999 -- Viagra has FDA approval for the treatment of
sexual impotence in men only. Ever since hitting the market in 1998 Viagra has
seen unprecedented success even at $10 a tablet men are lining up at their
doctor's offices for prescriptions. But what about the millions of
perimenopausal women with sexual dysfunction? Dr. Steven Kaplan was interested
he has just published the first study of Viagra in women. Researchers at
Columbia University looked at the effect of Viagra on 33 menopausal women who
complained of decreased sex drive, painful intercourse, vaginal dryness,
difficulty achieving orgasm or inability to achieve orgasm. The women took 50mg
of Viagra one hour before intercourse. That came out to an average of three
times a week for 12 weeks. Only 7 women (21%) noticed an improvement with
Viagra. According to Dr. Kaplan "That's equal to the placebo (sugar pill)
response in men receiving Viagra. So that response might be a placebo effect
rather than a true improvement in sexual function due to the drug" Urology 53[3];481-86, 1999. Cincinnati, OH, - May 9, 1999 -- Finally after many years of court battles,
suits and counter suits the FDA has approved a plant based estrogen combination
that is virtually identical to Premarin. Wyeth-Ayerst, had for many years
successfully blocked the approval of a synthetic replacement for Premarin. Their
drug is the most prescribed estrogen on the market today and is the third most
prescribed medications of all time. It has been available since 1942 and about 9
million women take it. Many women are surprised to find out that Premarin stands
for PREgnant MARes urINe, and in fact is made from horse urine. Moreover many
horse enthusiasts including the Equine Advocates organization claim that horses
used in the manufacturing process are mistreated. Because of this many women
want to get off Premarin but there hasn't been a comparable product until now. Boston, MA, - May 2 1999, -- Vitamin D deficiency is more common than
previously thought. If you live in the northern latitudes (most of the US)you
may be at risk. Each year in the US, hip fracture results in approximately
300,000 hospital admissions. Close to 40% of all women will suffer some type of
fracture after age 50. Most of these fractures result from osteoporosis among
women who experience accelerated bone loss after menopause. A hip fracture can
be worse than you may think, 20% of women die as a result of the fracture, 25%
end up in a long care facility and less than 50% recover fully. JAMA1999;281:1505-1511. National Institutes of Health Recommendations
|
| age 51-70 | 400 IU |
| age 70 and above | 600 IU |
|
Click
here to read the study. Alternative medicine coming to an OB/GYN near you New York, NY -April 26, 1999 -- Soon you may be able to talk to your local
OB/GYN about "alternative treatments" for your menopausal symptoms and
health concerns. This month two mainstream medical publications, OBG
management and Ob. Gyn. News published feature articles on
alternative medicine and womens health. In case your wondering, alternative
medicine includes therapies not generally taught in American medical schools.
The more common alternative therapies are herbal medicine, acupuncture,
homeopathy, therapeutic massage and chiropractic. These treatments are most
often prescribed by non MD physicians such as naturopaths and chiropractors.
Traditional OB/GYN's, along with the (AMA) American Medical Association have
discouraged the use of alternative practices calling them unscientific. The American public is not as skeptical, 69% used some form of alternative
medicine last year. Preliminary results of a Menopause-Online survey show that
most women responding used some form of alternative medicine for their
menopausal symptoms or concerns. Patients who try unconventional therapies often find that they feel better. A
problem arises when they attempt to talk to their uninformed OB/GYN's about what
they are doing. Women are especially concerned about possible interactions
between herbs and other medications and hormones they may be taking. Hopefully
more MD's will be motivated to learn the basics of alternative medicine since so
many of their patients are already involved in these therapies and could use
their help. Ob.Gyn.News 1999;34:8,5. Fore more information visit the National
Center for Complimentary and Alternative Medicine. New Haven, CT -April 19, 1999 -- Many women report problems with short term
memory as they reach menopause. Where did I leave the car keys? What was your
name? If this sounds familiar, read on. JAMA1999;281:1197-1202. Past articles on Menopause-Update:
Peri Menopausal Symptoms Occur Earlier in African-American Women Philadelphia, PA -April 12, 1999 -- It seems that African-American women
start having hot flasher earlier than white women. According to a study
published in the Journal of General Internal Medicine. Researchers at the
University of Pennsylvania surveyed 436 women between the ages of 35 and 48.
They found 53% of African-American and 29% of white women complained of hot
flashes, almost twice as many African-Americans as white. More interesting is
that when asked what was your primary source of information on menopause , white
women reported using the media while African-American women asked friends and
family. Sadly neither group reported getting information from their health care
provider. August 15,1998 -- Evista (Raloxifene) the new non hormonal drug used to
prevent or treat postmenopausal osteoporosis may protect against heart disease
as well. Evista is the first of a new class of drugs called SERMS (selective
estrogen receptor modulators )to be given FDA approval for osteoporosis.
According to a new study Evista lowered LDL (bad cholesterol) by 12% and raised
HDL (good cholesterol) by 16%. Estrogen is even better at producing the same
changes, but many women will not ,or can not take estrogen. Further studies are
necessary to determine if these changes in cholesterol will offer real
protection against heart disease. WASHINGTON, DC August 5, 1998 -- Prometrium® synthesized
|
|
WASHINGTON, DC August 5, 1998 -- Prometrium® synthesized from yams,
will be the first natural "micronized" progesterone to be
widely available in pharmacies. Prometrium is identical to the
progesterone produced by the body. and should eventually replace the
progestins now on the market. Prometrium is a product of Solvay
Pharmaceutical. CHICAGO, IL Jul 23, 1998 -- Four new estrogen studies were presented
at the annual meeting of the American Diabetes Association. One study
showed that women who took estrogen therapy after menopause had a five
times reduction in their risk of developing adult onset diabetes. Two
more studies, involving over 15,000 women, showed that women with
diabetes on HRT had better control of their blood sugar than diabetics
not on HRT. These are preliminary findings and prospective studies need
to be done. However you and your doctor may want to consider these
findings when deciding if you should be on HRT. University of Cincinnati Launches Program to Help Close the
Knowledge Gap San Francisco, CA - October, 1998 -- In just over a year, 50 million
American women will have reached menopause. These statistics suggest a troubling knowledge gap among the millions
of women expected to reach menopause by the year 2000 and who are, or
will soon be, making decisions about hormone replacement therapy (HRT).
"The vast majority of women entering menopause could benefit from
taking HRT, yet fewer than 25% of these women are actually doing so. I
think much of this can be attributed to the lack of awareness about the
health role that hormones play for women, especially as they reach
menopause," says Dr. Robert W. Rebar, professor and chairman of
Obstetrics and Gynecology at the University of Cincinnati College of
Medicine. According to the survey, women age 40 and over are divided in
their feelings about trying hormone replacement therapy. Regardless of
whether or not they have experience with the therapy, 42% say they would
use HRT if entering menopause today, while 41% said they would not. Many women who might benefit from HRT are not convinced they need it.
Of the women who said they would not take HRT if they became menopausal
today, 18% said they didn't think it was necessary; another 32% wouldn't
take it, but aren't sure why. Twenty percent of the women who would not
take HRT cited side effects as deterrents. Eleven percent cited fear of
the risks associated with HRT, even though the benefits of HRT are
well-established. Why Women - and Their Physicians - Should Find Knowledge Gap
Disturbing Information Overload, But Little "Knowledge" Columbia, MO. July 3, 1998 -- DHEA has been the subject of several
popular books and news articles lately. Some studies report that it may
have benefits in improving mood, mental functioning, bone density and
immune function in post menopausal women. DHEA does decline after
menopause. Let's remember a prospective case-control study on over 200
samples. DHEA was measured in the blood of 71 healthy postmenopausal
women who were not taking estrogen and developed breast cancer up to 10
years later. These blood samples were compared with matched women who
did not develop breast cancer. The findings showed that women with the
highest levels of DHEA were the most likely to develop breast cancer.
The higher the DHEA the greater the risk of cancer. These results are
sobering and should be taken into consideration before you self medicate
with this over the counter hormone. Dorgan JF, et al : Relationship of Serum dehydroepiandrosterone
(DHEA), DHEA Sulfate, and 5-androsterone-3-beta,17betadiol to the risk
of breast cancer in postmenopausal women. Cancer Epid Biomarkers
Prevention 6 :177-81, 1997. NEW YORK, NY June 23 1998 -- As we have reported before, there were
two studies on vitamin E and hot flashes in the 1940's. We have been
waiting for 50 years for more information. Now a double-blind,
placebo-controlled study of vitamin E therapy for hot flashes in breast
cancer survivors is in. The study used 800 IU a day for 4 weeks. The
results showed that vitamin E reduced hot flashes by 25% the placebo
reduced hot flashes by 22%. Vitamin E was only 3% more effective than
placebo. Not very encouraging. LOS ANGELES, CA June 15, 1998 -- OB-GYN NEWS Reports Viagra's
potential in women draws interest. Apparently since news of Viagra's
HUGE success in men has hit the press women are asking, can it help me?.
Viagra is known to enhance blood flow to "erectile tissue", in
men erectile tissue is located in the penis. Women have erectile tissue
too, in the clitoris. Will increasing blood flow to the clitoris have an
impact on sexual functioning in women? Many postmenopausal women report
a decrease in sexual response. No data exists for Viagras effect in
women. Pfizer, the manufacturer is sponsoring a study involving several
hundred women in Europe to determine if there is a place for Viagra in
treating female sexual dysfunction. Keep watching for news from Europe
on Viagra in women. INDIAN WELLS, CA June 12, 1998 -- Post menopausal women who used
estrogen had a 20% lower risk of developing colon cancer than women who
never used estrogen. This is a new finding in more than 7,000 women.
This study confirms 9 previous studies that have looked at women using
estrogen and the risk of colon cancer. This study was presented at the
annual meeting of the Pacific Coast Fertility Society. New York, N.Y. June 3, 1998 -- A new study just published in Neurology
(1998;50:368-373) According to Karen Bodenhorn, President and CEO of the California Center for Health Improvement, "This is a significant finding and highlights the critical role the media plays in disseminating health information to women who make the majority of health decisions for themselves and their families. This information arms women with the information they need to then turn to their own health care providers for specific and personal advice." The statewide telephone survey of 657 California women age 40 - 64
was conducted April 14 - May 12, 1998 for the Foundation for
Osteoporosis Research and Education by The Field Institute and the
California Center for Health Improvement. Prevention for
Menopause-Related Health Risks Is Critical. Fifty-nine percent of the
women in the surveyed age group were at menopause or were
postmenopausal. After the onset of menopause and the corresponding loss
of estrogen, women are at increased risk of developing a number of
diseases, including osteoporosis and heart disease. Nutrition, exercise
and access to medical treatment can prevent the consequences of these
diseases. According to the findings, in some cases women are getting
preventive treatment information and acting on it. For instance, 77
percent of women surveyed had mammograms within the last two years, but
an extremely small percentage (10 percent) were given bone density
scans. The survey findings indicate many women have made some changes,
or are willing to make changes for their health. Specifically, they
indicated a willingness to change their diet (79 percent), increase
their amount of exercise (72 percent), or use herbal remedies, daily
vitamins or mineral supplements (69 percent) for conditions associated
with menopause. Willingness to take such preventive health steps
includes large majorities of both pre- and post-menopausal women and
cuts across all racial/ethnic subgroups of the California population.
"Why haven't doctors discussed the full range of menopause-related
prevention and treatment options with these women? Clearly, women want
to age well. To assist in meeting this goal, new policies-including
policies targeting public and medical education and continuing
education- need to be established," said Bodenhorn.
PARACELUS DIGEST, May 18,1998 -- In a randomized, placebo-controlled
double-blind study, two groups each containing 20 patients with
menopause-related symptomology were treated for a period of 8 weeks with
kava extract 3 X 100 mg/day or a placebo preparation. Kava is an
Polynesian herb used for centuries in social ceremonies and more
recently, in the west for anxiety. The overall score of anxiety
symptomology revealed a significant difference in the drug-receiving
group vis-a-vis the placebo group already after only 1 week of
treatment. Improvement in depressive mood, subjective well-being
(patient diary), severity of the disease, and the climacteric
symptomology over the overall period of treatment demonstrates a high
level of effectiveness of kava extract in neuro vegetative and
psychosomatic dysfunctions in the climacteric, associated with very good
tolerance of the preparation. For more information CLICK HERE : WASHINGTON, May 14, 1998 -- The Women's Health Initiative is a eight-year federally funded study of postmenopausal women. It is now in its fourth year. The study is following 124,000 women in forty centers in the U.S. Women between the ages of 60 and 79 are still needed. You can help determine what the effects of diet, HRT, calcium and vitamin D are on heart disease cancer and osteoporosis If you are interested, please call toll free, 800-54-WOMEN. Tamoxifen prevents breast cancer, but at what cost? BETHESDA, MD. May 6, 1998 -- Tamoxifen (Nolvadex®)is a SERM (Selective Estrogen Receptor Modulator), similar to a new drug called Evista® which you may have read about here. Tamoxifen has been used for several years in women who have had breast cancer to prevent reoccurrences. Now the Breast Cancer Prevention Trial reports on more than 13,000 women at high risk of developing breast cancer who took tamoxifen. The study showed a 45% reduction in breast cancer among women taking tamoxifen however they had a higher risk of endometrial (uterine) cancer and blood clots in the lungs two of which were fatal. Physicians were advised against quickly starting women on tamoxifen until the data could be further analyzed. It may be in the near future that certain women who are at high risk of breast cancer and low risk of endometrial cancer or who have had a hysterectomy may be put on tamoxifen, Evista® or a similar drug. For more information on Breast Cancer click here Womens Cancer Network For more information on Evista® click here EVISTA Vitamin D deficiency more common then thought BOSTON, MA. May 1,1998 -- Researchers at Massachusetts General Hospital reporting in The New England Journal of Medicine have found high rates of vitamin D deficiency in patients not at risk for vitamin deficiencies. In the study, 42% of 77 patients at age 44, on average, were found to have low levels of vitamin D. Surprisingly 37% of the patients found to have low levels of vitamin D reported that they consumed at least the recommended amount of vitamin D for their age group. We know low levels of vitamin D can worsen osteoarthritis and contribute to osteoporosis. Perhaps more Americans should consider vitamin D supplementation. For more information see : Calcium and Vitamin D. Multiple vitamins. Topical Progesterone Cream Can Cause Overdose KENT, WA. April 7, 1998 -- Information released today from a major hormone testing lab indicates women using topical progesterone cream may be over dosing on it. In a letter to the editor of The Journal of Alternative and Complementary Medicine Michael Farhat, M.D. of Diagnos-Techs, Inc. reports on two women using progesterone cream as prescribed resulting in abnormally high progesterone levels. These high levels can result in water retention, breast engorgment and mild to moderate depression. Dr.Farhat recommends that women using progesterone creams should be closely monitored for over dosage. New Low Dose Estrogen Approved for Osteoporosis Treatment MARIETTA, GA. March 21, 1998 -- Solvay Pharmaceuticals, Inc., announced today that it received approval from the U.S. Food and Drug Administration to market the lowest oral estrogen dose -- 0.3 mg ESTRATAB (Esterified Estrogens Tablets, USP) -- for the prevention of osteoporosis. In a two-year clinical trial, women on 0.3 mg ESTRATAB Tablets -- esterified estrogens synthesized from soy and yam plant sources -- showed increased bone mineral density over baseline in the spine, hip and whole body. Women taking the low dose also experienced fewer side effects, such as headache, nausea, breast tenderness, and vaginal bleeding, than women on higher doses. Alternative Medicine Conference touches on women's health Issues BOSTON, MA. March 7,1999 -- Researchers, Physicians, Nurses and Government officials gathered in Boston this week to discuss the "scientific basis of alternative medicine". Most of the research presented centered on acupuncture, therapeutic message, homeopathy and herbs. Several herbs were discussed as alternatives to estrogen for menopausal symptoms. The herbs were chasteberry for hot flashes, St. John's Wort for irritability, and valerian for insomnia. Dr. Andrew Weil felt that Kava the Polynesian intoxicant, will replace St. John's Wort as the most talked about herb this year. Kava is used as a mild tranquilizer and sleep aid. Soy Food May Help Hot Flashes BOLOGNA, ITALY March 1, 1998 -- Eating tofu and other soy foods which contain Phytoestrogens may decrease hot flashes during menopause. Postmenopausal women who do not want to take HRT may be able control their hot flashes by supplementing their diet with soy protein. Dr. Domenico De Aloysio of the University of Bologna reports that in 51 women studied, hot flashed decreased by 45% after 12 weeks of eating 60g of soy protein a day.Obstetrics & Gynecology (1998;91:5-11). Hormone Replacement Therapy may Fight Hardening of the Arteries CHICAGO, IL. February 18, 1998 -- HRT (Hormone Replacement Therapy) has been associated with a decreased risk of coronary artery disease in postmenopausal women. Researchers at Rush Heart Institute and the University of Illinois reported on 899 women. All women underwent a new type of x-ray called electron beam tomography. This new scan can measure how much calcium is in the arteries of the heart. The women not on HRT had more calcium than women on HRT. Less calcium is associated with less plaque and less heart disease. This is another study in favor of HRT since heart disease is the number one killer of women in The United States. Am Heart J 1997; 134 115-119. Risk of Heart Disease in WOMEN reduced by vitamin B6 and folate BOSTON, MA. February 3, 1998 -- Finally a study on heart disease in WOMEN. In this weeks issue of The Journal of the American Medical Association Data from the Nurses Health Study including over 80,000 women has been analyzed with respect to vitamin B6 and Folate. The data suggests that a daily intake of folate and vitamin B6 GREATER than the current recommended dietary allowance may be important in the prevention of heart disease in women. Of the over 80,000 women reviewed, those who had the highest intake of folate and vitamin B6 had the lowest incidence of heart disease. What does this mean? There may be changes in the RDA within the next year for vitamin B6 and folate. But why wait? The highest intake of vitamin B6 and folate which was associated with a decrease in heart disease is easily obtainable with a vitamin B supplement. At this point the only risk is to your pocketbook. The benefits may be tremendous. For more information click on the following Vitamin
B6 and Folate. NEW YORK, N.Y. January 22, 1998 -- Postmenopausal women who add supplemental calcium to an estrogen regimen gain significantly more bone mass than women using estrogen or calcium alone, according to findings from a meta-analysis of studies that measured bone mass in postmenopausal women. Dr Jeri W. Nieves at Columbia University in New York included 31 published studies in the meta-analysis. They found that by adding calcium to a regimen of estrogen bone mass in the arm increased two and a half times greater then with estrogen alone over a one year period. Am J Clin Nutr 1998;67 18-24,5-6. See Calcium. GOTHENBURG, SWEDEN. January 8, 1998 -- As many as 40% of women in Sweden reported the use of herbal compounds for relief of their menopausal symptoms. Ginseng's impact on quality of life was compared with placebo ( sugar pill ) over a 16 week period on 382 postmenopausal women. Ginseng provided better overall symptomatic relief then placebo. There was no improvement in frequency of hot flashes. This is another good European study that needs to be elaborated on with a larger population. Free Communication : Abstracts from the Eighth Annual Meeting of the North American Menopause Society Menopause: 4,4; 243, 1997. See Korean
Ginseng. MODENA, ITALY January 1, 1998 -- Researchers at two Italian Universities report that the decline in "mood" or "well-being" scores on standard psychological tests taken by postmenopausal women may be due to the loss of estrogen. A cross-sectional study of 1,031 women showed depression and anxiety significantly higher in postmenopausal women then in perimenopausal women. Postmenopausal women taking HRT (estrogen and progesterone)had the lowest incidence of depression and anxiety even lower than the perimenopausal women. Menopause 1997 4 206-211. For more information on depression click HERE AKASHI, JAPAN. December 24, 1997 -- Atherosclerosis (hardening of the arteries) and osteoporosis (thinning of the bones) are common in postmenopausal women. Could they be connected? Low levels of vitamin D may be associated with the movement of calcium from the bones to the arteries. Can higher vitamin D levels move calcium from the arteries to the bones thereby solving two common postmenopausal problems. More studies are underway. Be sure you are getting adequate levels of vitamin D. If you live in the northern latitudes or spend much of the year indoors you probably need a vitamin D supplement.Stroke1997;1730-1732,1755-1760. See Vitamin
D. BETHESDA, MN. December 17, 1997 -- According to experts at the National Institutes of Health acupuncture is an effective primary treatment for certain types of pain and nausea. There is "clear evidence" that acupuncture is effective for morning sickness of pregnancy, post operative pain and "sufficient evidence" for treating menstrual cramps, headache and other conditions. The full NIH Consensus statement is available here NIH-Acupuncture. New Drug for Menopause Approved INDIANAPOLIS, December 10, 1997 -- Eli Lily and Company reports that its new drug, Evista® (raloxifene) the first among a new class of drugs called selective estrogen receptor modulators ( SERM ), Has received FDA approval. Lilly expects the drug to be in pharmacies by January. Raloxifene has been approved for the prevention and treatment of osteoporosis (thinning of the bones).Evista® does not PREVENT menopause or REVERSE menopause. Evista® may protect against cardiovascular disease the same way that estrogen does and it does NOT appear to stimulate the breast or uterus the way estrogen does. Evista® does not treat or prevent hot flashes, vaginal dryness or other changes seen with menopause and should not be taken by women who have or have had DVT (blood clots in the veins). New Menopause Drug Raloxifene moves toward FDA approval BETHESDA, MD. November 25, 1997 -- The FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 8-4 to recommend approval of Evista, for the prevention of osteoporosis in postmenopausal women. Eli Lilly & Co. hopes the drug will be on the market within six months. Evista is a (SERM) a new class of estrogen receptor modulating drugs which means it has some of estrogens effects but not others. Eli Lilly claims the drug can lower your chance of getting breast cancer by 60% and it may also protect against uterine cancer. The studies available for review are short term the National Women's Health Network has called for longer studies since if the drug is used for the treatment of osteoporosis it will need to be taken for many years. Pfizer and SmithKline Beecham have similar drugs in testing for the treatment of osteoporosis. DHEA studied for use in postmenopausal women QUEBEC, CANADA. November 17, 1997 -- Researchers at Laval University in Quebec feel that (DHEA) dehydroepiandrosterone should be further investigated as a new treatment for menopausal symptoms. In a small study 14 postmenopausal women used DHEA cream for one year. These women showed a significant (2%) increase in bone mineral density and a stimulating effect on the vaginal mucosa, but not on the uterus. There were problems with facial hair and acne. They concluded " It is possible that DHEA replacement therapy could not only correct, but also prevent, the multiple problems associated with menopause. J Clin Endocrinol Metab 1997;82:3498-3505. Lycopene Linked to Decreased Risk of Heart Attack CHAPEL HILL, NC. November 10, 1997 -- Lycopene, a carotenoid found in tomatoes and taken in tablet form by many Americans may protect against myocardial infarction (heart attack) by reducing the risk in half in those with a high intake. Biopsies were taken from a large group of subjects and tested for vitamin A, E, beta-carotene and lycopene. Lycopene was the only substance found protective for MI risk. Lycopene may account for the protective effect of high vegetable consumption on MI risk. It seems prudent based on this information to increase your intake of vegetables to the recommended 7-9 servings a day or consider a Lycopene supplement. Am J Epidemiol 1997;146:618-626. Hormone Replacement Therapy Accelerates Wound Healing MANCHESTER, UK. October 30, 1997 -- Researchers at the University of Manchester report in the November issue of Nature Medicine that "...hormone replacement therapy increases the rate of wound healing to levels similar to that seen in young women. The study included 30 women, 10 postmenopausal women on HRT for at least 3 months, 10 premenopausal women and 10 postmenopausal women with no history of HRT use. The postmenopausal women on HRT showed a marked acceleration in the rate of wound healing. We may see new uses for estrogen cream in the near future. The National Institutes of Health will study St.Johns wort. WASHINGTON D.C. October 26, 1997 -- The National Institutes of Health is initiating the first US trials of St. John's Wort, an herb used in europe to treat postmenopausal mood changes and depression. The three year study will take place at Duke University Medical Center and will begin next spring. The trial will involve 336 patients with depression, one-third will receive 900 mg of St. John's Wort a day, one-third will take a placebo and one-third will take a traditional anti-depressant drug. It's about time we start to catch up with the Europeans in this field. Tofu may help prevent uterine cancer HONOLULU, HAWAII, October 23, 1997 -- A diet high in soybean products such as tofu is associated with a lower risk of developing endometrial cancer, says researchers at the University of Hawaii. In a study published in The American Journal of Epidemiology (1997;146:294-306) of 332 women with endometrial cancer and 511 without cancer. It was determined that those with the diet highest in soy, and other beans were 54% less likely to develop endometrial cancer. go to soy foods. Calcium/vitamin D reduce fracture risk in postmenopausal women BOSTON, MASS, October 11, 1997 -- Daily supplementation of the diet with calcium and vitamin D may reduce the risk of bone fractures according to researchers from Tuffs University in Boston. In a recent study published in The New England Journal of Medicine (1997;337:670-676), 389 men and women over the age of 65 took 500mg. of calcium and 700 IU of vitamin D at bedtime for three years. These men and women were compared to a similar group who did not take the supplements. After three years the group that took the vitamin and mineral supplement had a fracture rate of 5.9% compared to a 12.9% fracture rate for the group that did not take the supplements. Calcium and vitamin D tablets are a widely available ,safe and inexpensive way to help protect your bones. Dr. Susan Love, Best-Selling Author takes on Hormone Replacement Therapy LOS ANGELES, CALIFORNIA, September 25,1997 -- Dr. Susan Love's new book Making Informed Choices About Menopause ( New York: Random House, 1997 ) is causing quite a stir among the ranks of top OB/GYN's. Her statements are infuriating some. She says hormones "can cause health problems at least as serious as those the medications are supposed to prevent... One of the things I ask is, what is the risk? The risk of Acupuncture, exercise or eating more tofu is very small from what I can tell. I would much rather see people take black cohosh ( Cimicifuga racemosa ) than take something that has the potential risk of cancer." Dr. Love is a Harvard trained general surgeon, but her critics say she has no experience in primary care, where the heart disease and hip fractures are generally seen. Many physicians disagree with her suggestion that women suffer more from breast cancer than from heart disease. The numbers we have seen seem to support their view. I'm sure we will be hearing more from Dr. Love. Women may benefit from folic acid supplementationg SAN ANTONIO, TEXAS, September 20, 1997 -- You may have read about homocysteine in the New York Times Magazine last month. It is a naturally occurring amino acid which has been implicated in heart disease. Now a study of 366 postmenopausal women with elevated homocysteine levels showed the women with the highest levels had twice the chance of stroke. We know folic acid, also known as folate supplementation can reduce high levels of homocysteine in the blood. It may be prudent to start taking folic acid. The RDA is 0.4 mg a day. Many multiple vitamin tablets already contain it. Look on the bottle. Estrogen can improve memory in old age HALIFAX, NOVA SCOTIA, September 17, 1997 -- Yet another study, this time out of Canada showing that estrogen therapy can improve memory. A group of 72 year old women ( we don't know how many ) on HRT were compared with 72 year old women not on HRT. The women taking estrogen performed better in several memory tests than the women not on estrogen. This is more evidence that there is a estrogen / memory connection. We will have to wait for the study to be published for more info. Very low dose estrogen may protect from bone loss UPPSALA, SWEDEN, September 11, 1997 -- In a small study reported in The American Journal of Obstetrics and Gynecology ( 1997;117:115-9 ) twenty women over the age of 60 were given low dose estrogen via vaginal ring. A new ring was inserted each month for six months. This low dose was shown to increase bone density by 2.1% verses a loss of bone density of 2.7% in women not using estrogen. While these results are encouraging we need to look at the risk of endometrial cancer in these women since they were not receiving progestin. Hormone therapy found to reduce risk of arthritis LONDON, ENGLAND, September 4, 1997 -- One form of arthritis or joint disease is called osteoarthritis. Osteoarthritis usually affects older women, unlike rheumatoid arthritis which can affect women at any age. Previous studies have suggested that HRT ( Hormone Replacement Therapy ) has a protective effect against osteoarthritis. Now, a larger study of 606 women age 45-64, who used HRT for more than 12 months, were shown to be three times less likely to have osteoarthritis in their knees, than women not taking HRT. More studies are needed and the protective effect was not noted in the hands of these women. But this is encouraging news for women trying to decide if HRT is right for them. Annals of Rheumatic Diseases ( 1997;56:432-434 ) New help line established CLEVELAND, OHIO, August 25, 1997 -- The North American Menopause Society has established a 1-900 number to provide consumer education by phone on a wide range of menopausal issues. The number is 1-900-370-NAMS (1-900-370-6267). The charge is $1.95/minute and the average call length is five minutes or about $10.00. HRT can slow post menopausal weight gain The PEPI Study, August 1, 1997 -- The Post menopausal Estrogen/Progestin Intervention trial (PEPI) is studying 875 post menopausal women for 13 years. Data shows that women on HRT (Hormone Replacement Therapy) gained 2.2 pounds LESS than women who are not on HRT. Smokers did not show this slowing of weight gain. This is encouraging news for women considering HRT...Findings published in J Clin Endocrinol Metab. (1997; 82: 1549-1556.) Estrogen may help prevent cataracts MADRID, SPAIN, July 28, 1997 -- Researchers in Madrid compared nineteen women taking estrogen for more than four years with twenty women who took no estrogen. Twenty-three men were used as controls. They found significantly higher transparency of the lenses of the women on estrogen as compared to either the men or the women not taking estrogen therapy. This is a small sample and a preliminary finding, but something to be considered in the equation of pluses and minuses of HRT for each individual. …Findings published in Ophthalmology. (1997; 104:970-973.). Designer Estrogens INDIANAPOLIS, July 23, 1997 -- Eli Lily and Company reports that its new drug, Evista® (raloxifene) is a first among a new class of drugs called selective estrogen receptor modulators. This new class of drugs can be used in place of traditional hormone replacement therapy for prevent and treating osteoporosis. Evista® is on the fast tract for FDA approval. In a clinical trial of 12,000 women, Evista® increased bone density of two to three percent and reduced (the bad) cholesterol. There was no stimulation of breast tissue, which could lead to breast cancer. Estrogen may be prescribed to treat women with high cholesterol CHICAGO, July 17, 1997 -- Premarin® was compared to Provachol® in a sixteen-week study of seventy-six postmenopausal women. Provachol®, a cholesterol-lowering drug decreased bad cholesterol (LDL) by twenty five percent and increased HDL or good cholesterol by four percent. On the other hand, Premarin® decreased LDL cholesterol by fourteen percent and increased HDL cholesterol by twenty three percent. Estrogen may be an option for managing postmenopausal women with high cholesterol. The combination of both drugs showed the best results. They decreased LDL by twenty nine percent and increased HDL by twenty one percent. (Reported in the Archives of Internal Medicine, 1997; 157:14186-92.) Ginkgo reduces sex dysfunction in patients on antidepressant therapy SAN DIEGO, July 15, 1997 -- Gingko biloba is a herb in the news recently. It is derived from a common Asian tree imported to the U.S. in the early part of this century as an ornament. Dr. Allen J. Cohen reported on his experience at the annual meeting of the American Psychiatric Association. Ninety one percent of thirty-three women treated with 60 - 120 mg. of Ginkgo three times a day and seventy-six percent men reported alleviation of diminished libido. These participants were all on antidepressant therapy. Can these results be applied to the common complaints of postmenopausal women? Not yet, but we all will be watching this interesting herb closely. NY Times / CBS News Poll Finds Women are taking health matters into their own hands NEW YORK, NY, June 22, 1997 -- When asked where do you get most of your medical information? 28% said from newspapers and magazines, 31% from TV and only 13% from doctors. When asked how often do doctors talk down to you? 58% said most or some of the time. 48% of women leave the doctors office with unanswered questions and 39% have tried or thought about trying alternative medicine. Non hormonal Drug Approved for the Prevention of Osteoporosis ROCKVILLE, MD, June 15, 1997 -- Fosamax®, a prescription drug, has been used since 1995 for the Treatment of osteoporosis may now be used for the Prevention of osteoporosis. The only other FDA approved drug for the prevention of osteoporosis is estrogen. The most appropriate use for this drug would be in postmenopausal women who have osteoporosis, as demonstrated by bone densitometry, and who for some reason can't take estrogen. Estrogen therapy lowers cholesterol in postmenopausal women CHICAGO, June 9, 1997 -- Estrogen therapy lowers in postmenopausal women. In a clinical study just completed, it was observed that women taking Premarin® over a sixteen-week period experienced a 13.5 percent decline in LDH ("bad") cholesterol and raising the levels of HDL ("good") cholesterol. That translates into a forty to fifty percent decrease in the risk of a heart attack. Chinese herb shows no effect in menopause study OAKLAND, CA, June 1, 1997 -- The Chinese herb dong quai, which has been used for centuries as a treatment for menopausal symptoms, was no more effective than a placebo (sugar pill) in controlling hot flashes. This is the result of a double-blind, randomized study. The study was conducted at Kaiser Permanente in Oakland, California on seventy-one postmenopausal women. Dong quai was given at 4.5 grams per day for six weeks. Thirty three percent of the women taking dong quai felt good relief of their hot flashes. However, twenty nine percent of the women on the placebo also had good relief -- the well-known placebo effect. Chinese herbs are often used in combinations, therefore more studies are needed. Gel appears effective INDIAN WELLS, CA, June 1, 1997 -- A progesterone gel is now being studied and preliminary reports are encouraging. The gel is applied to the skin like a patch, but it is without the adhesive of a patch and therefore without the irritation the adhesive can cause. The progesterone gel is absorbed in a natural and continuous fashion through the skin. This continuous flow of the hormone into the circulation is ideal. Generic Premarin® Not Approved: WASHINGTON, May 5, 1997 -- The FDA has NOT approved a generic form of the most widely prescribed estrogen, Premarin®. The FDA has concluded that there is a need for the ingredients in Premarin® to be more clearly identified. Premarin® is a combination of estrogens derived from pregnant mare's urine. Hormone Replacement in Breast Cancer Survivors: CHICAGO, April 29, 1997 -- There is exciting news for those women who have been diagnosed with, or having had a history of, breast cancer. Gynecology Oncology published a study indicating that estrogen replacement therapy may no longer be contraindicated. Traditionally, it has been discouraged for women who have been treated for breast cancer as it was felt ERT would lead to a reoccurrence of the cancer. Further studies are still needed to assess ERT's safety, but as the number of breast cancer survivors increases, so does the demand for dependable ERT information.
|